ReviewPharmaceuticals (Basel, Switzerland)2022

JAK2 in Myeloproliferative Neoplasms: Still a Protagonist.

Michael Stephan Bader et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.